Ingela Franck Lissbrant

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 12

Top Topics

Loop Mediated Isothermal Amplification

Electronic Health Record

Radical Prostatectomy

Prostate Cancer

Top Venues

Acta oncologica (Stockholm, Sweden)

Scandinavian journal of urology

This page only lists publications with an associated author ORCID identifier.

Publications

Rolf Gedeborg, Hans Garmo, Camilla Thellenberg Karlsson, Giuseppe Fallara, Johan Styrke, Ingela Franck Lissbrant, Pär Stattin
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study. Acta oncologica (Stockholm, Sweden) 61 (3) (2022)
Charlotte Alverbratt, Hanna Vikman, Marie Hjälm Eriksson, Pär Stattin, Ingela Franck Lissbrant
Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records. Scandinavian journal of urology 56 (2) (2022)
Giuseppe Fallara, Fredrik Sandin, Johan Styrke, Stefan Carlsson, Ingela Franck Lissbrant, Johan Ahlgren, Ola Bratt, Mats Lambe, Pär Stattin
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic. Scandinavian journal of urology 55 (3) (2021)
Giuseppe Fallara, Charlotte Alverbratt, Hans Garmo, Hanna Vikman, Marie Hjelm Eriksson, Ingela Franck Lissbrant, Pär Stattin
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden. Acta oncologica (Stockholm, Sweden) 60 (12) (2021)
Gincy George, Hanna Vikman, Rolf Gedeborg, Ingela Franck Lissbrant, Hans Garmo, Johan Styrke, Mieke Van Hemelrijck, Pär Stattin
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden. Acta oncologica (Stockholm, Sweden) 60 (4) (2021)
Kerri Beckmann, Hans Garmo, Ingela Franck Lissbrant, Pär Stattin
The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries. Cancers 13 (4) (2021)
Ingela Franck Lissbrant, Marie Hjälm Eriksson, Mats Lambe, Magnus Törnblom, Pär Stattin
Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Register of Sweden. Scandinavian journal of urology 54 (3) (2020)
Giuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, Francesco Montorsi, Rolf Gedeborg, Fredrik Sandin, Pär Stattin
Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in Sweden. Acta oncologica (Stockholm, Sweden) 60 (1) (2020)
Johanna Svensson, Ingela Franck Lissbrant, Oskar Gauffin, Marie Hjälm-Eriksson, Suzanne Kilany, Karin Fagerlund, Pär Stattin
Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden. Scandinavian journal of urology 55 (1) (2020)
Kerri Beckmann, Hans Garmo, Per Nilsson, Ingela Franck Lissbrant, Anders Widmark, Pär Stattin
Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016. Acta oncologica (Stockholm, Sweden) 59 (5) (2020)
Åsa Jellvert, Daniel Åhs, Josefin Olausson, Ingela Franck Lissbrant, Jan-Erik Damber, Karin Welén
Castration is a prerequisite for the inhibitory effect of metronomic chemotherapy on the growth of experimental castration-resistant prostate cancer. Acta oncologica (Stockholm, Sweden) 57 (7) (2018)
Ingela Franck Lissbrant, Eugenio Ventimiglia, David Robinson, Magnus Törnblom, Marie Hjälm-Eriksson, Mats Lambe, Yasin Folkvaljon, Pär Stattin
Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden. Scandinavian journal of urology 52 (2) (2018)